HERMIONE-13, NCT05173103: Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer |
|
|
| Recruiting | N/A | 150 | Europe | | University of Milano Bicocca | Advanced Breast Cancer, Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer | 01/24 | 01/24 | | |